| Status | Study |
| Recruiting |
Study Name: Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder Condition: Attention Deficit Disorder With Hyperactivity Date: 2016-10-31 Interventions: Drug: Immediate-release Methylphenidate Standard initial dose of 10 mg, twice or three times daily with |
| Recruiting |
Study Name: Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder Condition: Attention Deficit Disorder With Hyperactivity Date: 2016-10-14 Interventions: Behavioral: cognitive behavior group therapy |
| Recruiting |
Study Name: Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type Condition: Attention Deficit Disorder With Hyperactivity Date: 2016-08-31 Interventions: Behavioral: Cognitive-behavioral therapy |
| Completed |
Study Name: Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Condition: Attention Deficit Disorder With Hyperactivity Date: 2016-06-15 Interventions: Drug: mazindol |
| Completed |
Study Name: TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) Condition: Attention Deficit Disorder With Hyperactivity Date: 2014-03-07 Interventions: Drug: TRI102 formulation conta |
| Completed |
Study Name: Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD) Condition: Attention Deficit Disorder With Hyperactivity Date: 2010-07-09 Interventions: Other: Polysomnography Sleep s |
| Completed |
Study Name: Evaluation of Oral Needs of Children With Disorder Attention Deficit/Hyperactivity Disorder Condition: Attention Deficit Disorder With Hyperactivity Date: 2010-04-09 |
| Completed |
Study Name: Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) Condition: Attention Deficit Disorder With Hyperactivity Date: 2010-02-15 Interventions: Drug: Guanfacine Extended Release |
| Completed |
Study Name: An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) Condition: Attention Deficit Disorder With Hyperactivity Date: 2010-01-21 Interventions: Drug: OROS Methylphenidate HCl Osmotic Release Oral System (OROS) Methylphenidate HCl tablet will be giv |
| Completed |
Study Name: Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD) Condition: Attention Deficit Disorder With Hyperactivity Date: 2009-07-15 Interventions: Drug: duloxetine 60 mg capsule |